{"title":"Explainable Artificial Intelligence Models for Predicting Depression Based on Polysomnographic Phenotypes.","authors":"Doljinsuren Enkhbayar, Jaehoon Ko, Somin Oh, Rumana Ferdushi, Jaesoo Kim, Jaehong Key, Erdenebayar Urtnasan","doi":"10.3390/bioengineering12020186","DOIUrl":null,"url":null,"abstract":"<p><p>Depression is a common mental health disorder and a leading contributor to mortality and morbidity. Despite several advancements, the current screening methods have limitations in enabling the robust and automated detection of depression, thereby hindering early diagnosis and timely intervention. This study aimed to develop explainable artificial intelligence (AI) models to predict depression using polysomnographic phenotype data, ensuring high predictive performance while providing clear insights into the importance of features influencing the risk of depression. Advanced machine learning algorithms such as random forest, extreme gradient boosting, categorical boosting, and light gradient boosting machines were employed to train and validate the predictive AI models. Phenotype data from subjective health questionnaires, clinical assessments, and demographic factors were analyzed. The explainable AI models identified the important features, and their performance was evaluated using cross-validation. The study population, comprising 114 control participants and 39 individuals with depression, was stratified based on validated depression-scoring methods. The proposed explainable AI models achieved an F1-score of 85%, verifying their high reliability in predicting depression. Key features influencing the risk of depression, such as anxiety disorders, sleep efficiency, and demographic factors, offer actionable insights for clinical practice, highlighting the transparency of these models. This study proposed and developed explainable AI models based on polysomnographic phenotype data for the automated detection of depression and verified that these models help improve mental health diagnostics, enabling timely interventions.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 2","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11851660/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12020186","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Depression is a common mental health disorder and a leading contributor to mortality and morbidity. Despite several advancements, the current screening methods have limitations in enabling the robust and automated detection of depression, thereby hindering early diagnosis and timely intervention. This study aimed to develop explainable artificial intelligence (AI) models to predict depression using polysomnographic phenotype data, ensuring high predictive performance while providing clear insights into the importance of features influencing the risk of depression. Advanced machine learning algorithms such as random forest, extreme gradient boosting, categorical boosting, and light gradient boosting machines were employed to train and validate the predictive AI models. Phenotype data from subjective health questionnaires, clinical assessments, and demographic factors were analyzed. The explainable AI models identified the important features, and their performance was evaluated using cross-validation. The study population, comprising 114 control participants and 39 individuals with depression, was stratified based on validated depression-scoring methods. The proposed explainable AI models achieved an F1-score of 85%, verifying their high reliability in predicting depression. Key features influencing the risk of depression, such as anxiety disorders, sleep efficiency, and demographic factors, offer actionable insights for clinical practice, highlighting the transparency of these models. This study proposed and developed explainable AI models based on polysomnographic phenotype data for the automated detection of depression and verified that these models help improve mental health diagnostics, enabling timely interventions.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering